XML 64 R15.htm IDEA: XBRL DOCUMENT v2.4.0.6
Equity
3 Months Ended
Mar. 31, 2013
Stockholders' Equity Note [Abstract]  
Equity
Equity
Changes in equity for the three months ended March 31, 2013 and 2012 were as follows (in thousands, except share amounts): 
 
Gentiva Shareholders
 
 
 
 
 
Common Stock
 
Additional
Paid-in Capital
 
Retained
Earnings
(Deficit)
 
Treasury Stock
 
Noncontrolling Interests
 
 
 
Shares
 
Amount
 
 
 
 
 
Total
Balance at December 31, 2011
31,435,264

 
$
3,144

 
$
387,803

 
$
(178,131
)
 
$
(12,878
)
 
$
2,593

 
$
202,531

Comprehensive income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income

 

 

 
4,840

 

 
213

 
5,053

Total comprehensive income

 

 

 
4,840

 

 
213

 
5,053

Equity-based compensation expense

 

 
1,631

 

 

 

 
1,631

Net issuance of stock upon exercise of stock options and under stock plans for employees and directors
122,390

 
14

 
691

 

 

 

 
705

Distribution to partnership interests

 

 

 

 

 
(195
)
 
(195
)
Balance at March 31, 2012
31,557,654

 
$
3,158

 
$
390,125

 
$
(173,291
)
 
$
(12,878
)
 
$
2,611

 
$
209,725

 
 
 
 
 
 
 
 
 
 
 
 
 
 
Balance at December 31, 2012
32,009,286

 
$
3,201

 
$
399,148

 
$
(151,335
)
 
$
(17,852
)
 
$
1,538

 
$
234,700

Comprehensive (loss) income:
 
 
 
 
 
 
 
 
 
 
 
 
 
Net (loss) income

 

 

 
(207,177
)
 

 
121

 
(207,056
)
Total comprehensive (loss) income

 

 

 
(207,177
)
 

 
121

 
(207,056
)
Income tax expense associated with the exercise of non-qualified stock options

 

 
(304
)
 

 

 

 
(304
)
Equity-based compensation expense

 

 
1,813

 

 

 

 
1,813

Net issuance of stock upon exercise of stock options and under stock plans for employees and directors
501,401

 
50

 
942

 

 
(261
)
 

 
731

Distribution to partnership interests

 

 

 

 

 
(240
)
 
(240
)
Balance at March 31, 2013
32,510,687

 
$
3,251

 
$
401,599

 
$
(358,512
)
 
$
(18,113
)
 
$
1,419

 
$
29,644

Comprehensive loss amounted to $207.1 million for the first quarter of 2013 as compared to comprehensive income of $5.1 million for the first quarter of 2012.
On March 13, 2012, the Company announced that its Board of Directors had authorized the repurchase of up to $5,000,000 of shares of the Company’s outstanding common stock (the “2012 Repurchase Program”). During the three months ended March 31, 2013 and 2012, the Company did not repurchase shares of its outstanding common stock. As of March 31, 2013, the Company had remaining authorization under the 2012 Repurchase Program to repurchase common stock with an aggregate purchase price of up to $1.5 million, subject to the additional limitations set forth below.
The Company’s Credit Agreement provides for repurchases of the Company’s common stock not to exceed $5.0 million per year, and not to exceed $20.0 million per year if the consolidated leverage ratio is less than or equal to 3.5:1 immediately after giving effect on a pro forma basis to the repurchase. The indenture governing the Company’s Senior Notes also contains limitations on the Company’s repurchases of its common stock.